SciVision Biotech Inc. (TPE:1786)

SciVision Biotech Revenue

SciVision Biotech had revenue of 211.03M TWD in the quarter ending June 30, 2026, with 0.73% growth. This brings the company's total for the last twelve months to 889.15M, down -0.23% year-over-year. In the year 2025, SciVision Biotech had annual revenue of 886.62M with 0.37% growth. That makes SciVision Biotech the 31,949th largest company in the world by revenue and 1,635th in Taiwan.

• Revenue (ttm): 889.15M
• Revenue Growth: -0.23%
• P/S Ratio: 4.00
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 3.56B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Medical Device Manufacturing Department 852.27M 92.7%
• Beauty Management Service Department 66.92M 7.3%

By Geography

Chart

• Asia 589.41M 66.5%
• Europe 279.98M 31.6%
• America 17.24M 1.9%

Fiscal year ended Dec 31, 2025 See the full SciVision Biotech breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	886.62M	3.31M	0.37%
Dec 31, 2024	883.31M	170.32M	23.89%
Dec 31, 2023	712.99M	155.64M	27.93%
Dec 31, 2022	557.35M	51.81M	10.25%
Dec 31, 2021	505.54M	38.66M	8.28%

Data Source: S&P Global Market Intelligence Last updated: Aug 6, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 29, 2026

Data Sources Report a data error